HALO logo
halo search icon
SCYNEXIS, Inc.

US$0.67

Price Change Indicator
0.011 (1.68%)
SCYNEXIS, Inc.
SCYX · NAS

SCYNEXIS, Inc.

Start Trading SCYX for Free

US$0.67

Price Arrow0.011 (1.68%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusConsensus CheapEngulfing BullishHALO AllHALO Consensus Value
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

SCYNEXIS, Inc. Overview

SCYX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About SCYX

icon
icon

Telephone

1.201.884.5485

icon

Address

13th floor, 1 Evertrust Plaza, Jersey City, NJ 07302-6548

Description

SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.

SCYX Price Chart

Key Stats

Market Cap

US$52.18M

PE

2.40

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.56 - 1.31

Trade Value (12mth)

US$85,239.00

1 week

-11.24%

1 month

-38.04%

YTD

2.87%

1 year

-14.79%

All time high

150.00

Key Fundamentals

EPS 3 yr Growth

-88.30%

EBITDA Margin

-78.00%

Operating Cashflow

-$5m

Free Cash Flow Return

-9.80%

ROIC

-15.90%

Interest Coverage

-33.10

Quick Ratio

7.00

Other Data

Shares Outstanding (Fully Diluted)

51m

HALO Sector

Healthcare

Next Company Report Date

31-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

SCYX Announcements

Latest Announcements

DateAnnouncements
12 May 26
12 May 26
21 April 26
21 April 26
01 April 26

SCYX Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock1.4-0.44-0.17locklocklock
EPS (Fully Diluted)
 $locklocklocklock1.39-0.44-0.17locklocklock
Growth
 %locklocklocklock195.1-131.360.7locklocklock
PE
 Xlocklocklocklock1.632.72.4locklocklock
EV/EBITDA
 Xlocklocklocklock0.6N/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of SCYNEXIS, Inc. (SCYX:NAS)?
Halo FAQ
The current share price of SCYNEXIS, Inc. (SCYX:NAS) is USD$0.67.
What is the 52-week high share price for SCYNEXIS, Inc. (SCYX:NAS)?
Halo FAQ
The 52-week high share price for SCYNEXIS, Inc. (SCYX:NAS) is USD$1.31.
What is the 52-week low share price for SCYNEXIS, Inc. (SCYX:NAS)?
Halo FAQ
The 52-week low share price for SCYNEXIS, Inc. (SCYX:NAS) is USD$0.56.
What is the dividend yield for SCYNEXIS, Inc. (SCYX:NAS)?
Halo FAQ
SCYNEXIS, Inc. (SCYX:NAS) does not pay a dividend.
What was SCYNEXIS, Inc. (SCYX:NAS) last dividend payment?
Halo FAQ
SCYNEXIS, Inc. (SCYX:NAS) does not pay a dividend.
What is the franking level for SCYNEXIS, Inc. (SCYX:NAS)?
Halo FAQ
SCYNEXIS, Inc. (SCYX:NAS) has a franking level of 0.00%.
In which sector is SCYNEXIS, Inc. (SCYX:NAS) classified?
Halo FAQ
SCYNEXIS, Inc. (SCYX:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for SCYNEXIS, Inc. (SCYX:NAS)?
Halo FAQ
The current P/E ratio for SCYNEXIS, Inc. (SCYX:NAS) is 2.40.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial